Stadlbauer Andrea, Philipp Alois, Foltan Maik, Stadlbauer Christian, Schopka Simon, Schmid Christof, Keyser Andreas
Department of Cardiothoracic Surgery University Medical Center Regensburg, Germany.
Resusc Plus. 2025 Jul 14;25:101033. doi: 10.1016/j.resplu.2025.101033. eCollection 2025 Sep.
Pre-hospital extracorporeal cardiopulmonary resuscitation (ECPR) in out-of-hospital cardiac arrest is costly and resource-intensive. Low survival rates raise questions concerning efficacy of ECPR. We aimed to analyze survival and neurological outcome of these patients and the influence of underlying coronary artery disease as well as shockable heart rhythm leading to resuscitation.
Retrospective analysis of our ECMO database revealed 94 patients receiving ECPR for out-of-hospital cardiac arrest from September 2009 to May 2023. After exclusion of patients with pulmonary embolism, drowning or intoxication as confounders, 58 patients remained. Patients were divided into 2 groups depending on underlying coronary artery disease and initial heart rhythm. Primary outcome was survival to discharge and long-term survival, secondary outcome was neurological capacity analyzed with the cerebral performance category score (CPC).
26 patients (44.8 %) survived to discharge; 6 patients died during a median follow-up time of 1057.5 days. There was no significant difference concerning survival to discharge between the groups. Numerically, more patients with shockable rhythm and without coronary artery disease survived. Kaplan-Meier analysis revealed a survival benefit for patients with shockable rhythm without coronary artery disease ( < 0.007). 92.3 % of survivors had a CPC-Score of 1. CPC Score did not differ between the groups.
Though mortality in ECPR patients remains high with 55.2 %, long-term and neurological outcome with a CPC score of 1 is very good, especially of those with shockable rhythm and without coronary artery disease. Old age and duration of cardiopulmonary resuscitation pre-ECMO impair neurological outcome. Thus, on-site ECMO cannulation should be endorsed.
院外心脏骤停患者的院前体外心肺复苏(ECPR)成本高昂且资源消耗大。低生存率引发了关于ECPR疗效的质疑。我们旨在分析这些患者的生存情况和神经学转归,以及潜在冠状动脉疾病和可电击心律对复苏的影响。
对我们的体外膜肺氧合(ECMO)数据库进行回顾性分析,发现2009年9月至2023年5月期间有94例院外心脏骤停患者接受了ECPR。排除肺栓塞、溺水或中毒等混杂因素的患者后,剩余58例患者。根据潜在冠状动脉疾病和初始心律将患者分为两组。主要结局是出院生存率和长期生存率,次要结局是用脑功能分级(CPC)评分分析神经功能。
26例患者(44.8%)存活出院;6例患者在中位随访时间1057.5天期间死亡。两组间出院生存率无显著差异。从数字上看,可电击心律且无冠状动脉疾病的患者存活人数更多。Kaplan-Meier分析显示,可电击心律且无冠状动脉疾病的患者有生存获益(P<0.007)。92.3%的幸存者CPC评分为1。两组间CPC评分无差异。
尽管ECPR患者的死亡率仍高达55.2%,但CPC评分为1的长期和神经学转归非常好,尤其是可电击心律且无冠状动脉疾病的患者。高龄和ECMO前心肺复苏持续时间会损害神经学转归。因此,应支持现场进行ECMO插管。